Condition
Lower Respiratory Tract and Lung Infections
Total Trials
6
Recruiting
2
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed3
Recruiting2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07381790Recruiting
Modern Technologies in Lower Respiratory Tract Infections in Children
NCT06149494Phase 2Completed
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
NCT06201494Recruiting
Prospective Multicentre Study on Symptoms in First-onset Bronchial Asthma in Children and Adolescents
NCT06211985Not ApplicableCompletedPrimary
Copeptin: Disease Severity Indicator
NCT05380869Not ApplicableCompleted
POCT PCT in Outpatient LRTI
NCT02568358UnknownPrimary
DNA-based Testing in BAL of Lung Transplant Recipients With Suspected Non-viral Lower Respiratory Tract Infection
Showing all 6 trials